Systematic Literature Review and Expert Opinion for the Use of Viscosupplementation with Hyaluronic Acid in Different Localizations of Osteoarthritis

Alberto Migliore,1 Gianfranco Gigliucci,1 Lyudmila Alekseeva,2 Raveendhara R Bannuru,3 Tomasz Blicharski,4 Demirhan Diracoglu,5 Athanasios Georgiadis,6 Hesham Hamoud,7 Natalia Martusevich,8 Marco Matucci Cerinic,9 Jan Perduk,10 Imre Szerb,11 Tomáš Trč,12 Xavier Chevalier13 1Rheumatology U...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Migliore A, Gigliucci G, Alekseeva L, Bannuru RR, Blicharski T, Diracoglu D, Georgiadis A, Hamoud H, Martusevich N, Matucci Cerinic M, Perduk J, Szerb I, Trč T, Chevalier X
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2021
Materias:
Acceso en línea:https://doaj.org/article/faee5a4279c846028c070edd373158a7
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:faee5a4279c846028c070edd373158a7
record_format dspace
institution DOAJ
collection DOAJ
language EN
topic appropriateness
osteoarthritis
personalized medicine
viscosupplementation
Orthopedic surgery
RD701-811
Diseases of the musculoskeletal system
RC925-935
spellingShingle appropriateness
osteoarthritis
personalized medicine
viscosupplementation
Orthopedic surgery
RD701-811
Diseases of the musculoskeletal system
RC925-935
Migliore A
Gigliucci G
Alekseeva L
Bannuru RR
Blicharski T
Diracoglu D
Georgiadis A
Hamoud H
Martusevich N
Matucci Cerinic M
Perduk J
Szerb I
Trč T
Chevalier X
Systematic Literature Review and Expert Opinion for the Use of Viscosupplementation with Hyaluronic Acid in Different Localizations of Osteoarthritis
description Alberto Migliore,1 Gianfranco Gigliucci,1 Lyudmila Alekseeva,2 Raveendhara R Bannuru,3 Tomasz Blicharski,4 Demirhan Diracoglu,5 Athanasios Georgiadis,6 Hesham Hamoud,7 Natalia Martusevich,8 Marco Matucci Cerinic,9 Jan Perduk,10 Imre Szerb,11 Tomáš Trč,12 Xavier Chevalier13 1Rheumatology Unit - San Pietro Fatebenefratelli Hospital, Rome, Italy; 2Department of Metabolic Diseases of Bone and Joints, V.A. Nasonova Research Institute of Rheumatology, Moscow, Russian Federation; 3Center for Treatment Comparison and Integrative Analysis (CTCIA) at Tufts Medical Center, Boston, MA, USA; 4Lubelskie Centrum Diagnostyczne, Świdnik, Poland; 5Department of Physical Medicine and Rehabilitation, Istanbul University, Istanbul, Turkey; 6Department of Rheumatology, University of Ioannina, Ioannina, Greece; 7Department of Rheumatology Al Azhar University, Cairo, Egypt; 8Department of Rheumatology, Belarusian State Medical University, Minsk, Belarus; 9Division of Rheumatology, University of Florence, Florence, Italy; 10Department of Musculoskeletal Medicine and Sports, Hospital Košice -Šaca, Kosice Saca, Slovakia; 11Semmelweis University, Department of Traumatology Uzsoki Hospital, Department of Orthopaedics&Traumatology FIFA Medical Centre of Excellence Uzsoki u.29– 41, Budapest, Hungary; 12Department of Orthopaedic Surgery, Charles University and Motol University Hospital, Prague, Czech Republic; 13Rheumatology Division, Henri-Mondor Hospital, Créteil, FranceCorrespondence: Alberto MiglioreRheumatology Unit - San Pietro Fatebenefratelli Hospital, Rome, ItalyEmail reumafbf@libero.itAbstract: Osteoarthritis (OA) is a significant cause of disability. Considering the increasing diffusion of the viscosupplementation (VS) with hyaluronic acid (HA), the International Symposium Intra Articular Treatment (ISIAT) appointed a Technical Expert Panel (TEP) to identify the criteria for successful VS with a specific HA in OA; this through a systematic literature review (SLR), performed following the PRISMA guidelines interrogating Medline, Embase, Cochrane Library, Cumulative Index to Nursing and Allied Health Literature (CINAHL), Grey Matters and American College of Rheumatology (ACR/EULAR) databases and the opinion of international experts. The research included only studies on adults and humans without limitations of language or time of publication. Researchers extracted both quantitative and qualitative data from each study. Mixed Methods Appraisal Tool (MMAT) was used to perform quality analysis for the level of evidence. The SLR retrieved 385 papers, 25 of which were suitable for the analysis. The TEP focused on the different formulations of the product Sinovial® [HA 0.8%, HA 1.6%, HA 2%, 800– 1200 kDa, HA 3.2% (1400– 2100 kDa/65– 110 kDa)]. The choice was due to the vast amount of evidence available. The TEP weighed the evidence in two rounds of a Delphi survey; the results, and any disagreement, were discussed in a final session. Three domains were considered: 1) the patients’ characteristics associated with the best results; 2) the contraindications and the conditions linked to increased risk of failure; 3) the clinical conditions in which VS is considered appropriate. The TEP concluded that VS with HA is safe and effective in the treatment of knee and hip OA of grades I to III and that it is possible to undertake VS in other situations (eg grade IV Kellgren-Lawrence – KL); a comprehensive examination of the patient should be performed before the procedure.Keywords: appropriateness, osteoarthritis, personalized medicine, viscosupplementation
format article
author Migliore A
Gigliucci G
Alekseeva L
Bannuru RR
Blicharski T
Diracoglu D
Georgiadis A
Hamoud H
Martusevich N
Matucci Cerinic M
Perduk J
Szerb I
Trč T
Chevalier X
author_facet Migliore A
Gigliucci G
Alekseeva L
Bannuru RR
Blicharski T
Diracoglu D
Georgiadis A
Hamoud H
Martusevich N
Matucci Cerinic M
Perduk J
Szerb I
Trč T
Chevalier X
author_sort Migliore A
title Systematic Literature Review and Expert Opinion for the Use of Viscosupplementation with Hyaluronic Acid in Different Localizations of Osteoarthritis
title_short Systematic Literature Review and Expert Opinion for the Use of Viscosupplementation with Hyaluronic Acid in Different Localizations of Osteoarthritis
title_full Systematic Literature Review and Expert Opinion for the Use of Viscosupplementation with Hyaluronic Acid in Different Localizations of Osteoarthritis
title_fullStr Systematic Literature Review and Expert Opinion for the Use of Viscosupplementation with Hyaluronic Acid in Different Localizations of Osteoarthritis
title_full_unstemmed Systematic Literature Review and Expert Opinion for the Use of Viscosupplementation with Hyaluronic Acid in Different Localizations of Osteoarthritis
title_sort systematic literature review and expert opinion for the use of viscosupplementation with hyaluronic acid in different localizations of osteoarthritis
publisher Dove Medical Press
publishDate 2021
url https://doaj.org/article/faee5a4279c846028c070edd373158a7
work_keys_str_mv AT migliorea systematicliteraturereviewandexpertopinionfortheuseofviscosupplementationwithhyaluronicacidindifferentlocalizationsofosteoarthritis
AT gigliuccig systematicliteraturereviewandexpertopinionfortheuseofviscosupplementationwithhyaluronicacidindifferentlocalizationsofosteoarthritis
AT alekseeval systematicliteraturereviewandexpertopinionfortheuseofviscosupplementationwithhyaluronicacidindifferentlocalizationsofosteoarthritis
AT bannururr systematicliteraturereviewandexpertopinionfortheuseofviscosupplementationwithhyaluronicacidindifferentlocalizationsofosteoarthritis
AT blicharskit systematicliteraturereviewandexpertopinionfortheuseofviscosupplementationwithhyaluronicacidindifferentlocalizationsofosteoarthritis
AT diracoglud systematicliteraturereviewandexpertopinionfortheuseofviscosupplementationwithhyaluronicacidindifferentlocalizationsofosteoarthritis
AT georgiadisa systematicliteraturereviewandexpertopinionfortheuseofviscosupplementationwithhyaluronicacidindifferentlocalizationsofosteoarthritis
AT hamoudh systematicliteraturereviewandexpertopinionfortheuseofviscosupplementationwithhyaluronicacidindifferentlocalizationsofosteoarthritis
AT martusevichn systematicliteraturereviewandexpertopinionfortheuseofviscosupplementationwithhyaluronicacidindifferentlocalizationsofosteoarthritis
AT matuccicerinicm systematicliteraturereviewandexpertopinionfortheuseofviscosupplementationwithhyaluronicacidindifferentlocalizationsofosteoarthritis
AT perdukj systematicliteraturereviewandexpertopinionfortheuseofviscosupplementationwithhyaluronicacidindifferentlocalizationsofosteoarthritis
AT szerbi systematicliteraturereviewandexpertopinionfortheuseofviscosupplementationwithhyaluronicacidindifferentlocalizationsofosteoarthritis
AT trct systematicliteraturereviewandexpertopinionfortheuseofviscosupplementationwithhyaluronicacidindifferentlocalizationsofosteoarthritis
AT chevalierx systematicliteraturereviewandexpertopinionfortheuseofviscosupplementationwithhyaluronicacidindifferentlocalizationsofosteoarthritis
_version_ 1718376891059011584
spelling oai:doaj.org-article:faee5a4279c846028c070edd373158a72021-12-02T19:17:36ZSystematic Literature Review and Expert Opinion for the Use of Viscosupplementation with Hyaluronic Acid in Different Localizations of Osteoarthritis1179-1462https://doaj.org/article/faee5a4279c846028c070edd373158a72021-12-01T00:00:00Zhttps://www.dovepress.com/systematic-literature-review-and-expert-opinion-for-the-use-of-viscosu-peer-reviewed-fulltext-article-ORRhttps://doaj.org/toc/1179-1462Alberto Migliore,1 Gianfranco Gigliucci,1 Lyudmila Alekseeva,2 Raveendhara R Bannuru,3 Tomasz Blicharski,4 Demirhan Diracoglu,5 Athanasios Georgiadis,6 Hesham Hamoud,7 Natalia Martusevich,8 Marco Matucci Cerinic,9 Jan Perduk,10 Imre Szerb,11 Tomáš Trč,12 Xavier Chevalier13 1Rheumatology Unit - San Pietro Fatebenefratelli Hospital, Rome, Italy; 2Department of Metabolic Diseases of Bone and Joints, V.A. Nasonova Research Institute of Rheumatology, Moscow, Russian Federation; 3Center for Treatment Comparison and Integrative Analysis (CTCIA) at Tufts Medical Center, Boston, MA, USA; 4Lubelskie Centrum Diagnostyczne, Świdnik, Poland; 5Department of Physical Medicine and Rehabilitation, Istanbul University, Istanbul, Turkey; 6Department of Rheumatology, University of Ioannina, Ioannina, Greece; 7Department of Rheumatology Al Azhar University, Cairo, Egypt; 8Department of Rheumatology, Belarusian State Medical University, Minsk, Belarus; 9Division of Rheumatology, University of Florence, Florence, Italy; 10Department of Musculoskeletal Medicine and Sports, Hospital Košice -Šaca, Kosice Saca, Slovakia; 11Semmelweis University, Department of Traumatology Uzsoki Hospital, Department of Orthopaedics&Traumatology FIFA Medical Centre of Excellence Uzsoki u.29– 41, Budapest, Hungary; 12Department of Orthopaedic Surgery, Charles University and Motol University Hospital, Prague, Czech Republic; 13Rheumatology Division, Henri-Mondor Hospital, Créteil, FranceCorrespondence: Alberto MiglioreRheumatology Unit - San Pietro Fatebenefratelli Hospital, Rome, ItalyEmail reumafbf@libero.itAbstract: Osteoarthritis (OA) is a significant cause of disability. Considering the increasing diffusion of the viscosupplementation (VS) with hyaluronic acid (HA), the International Symposium Intra Articular Treatment (ISIAT) appointed a Technical Expert Panel (TEP) to identify the criteria for successful VS with a specific HA in OA; this through a systematic literature review (SLR), performed following the PRISMA guidelines interrogating Medline, Embase, Cochrane Library, Cumulative Index to Nursing and Allied Health Literature (CINAHL), Grey Matters and American College of Rheumatology (ACR/EULAR) databases and the opinion of international experts. The research included only studies on adults and humans without limitations of language or time of publication. Researchers extracted both quantitative and qualitative data from each study. Mixed Methods Appraisal Tool (MMAT) was used to perform quality analysis for the level of evidence. The SLR retrieved 385 papers, 25 of which were suitable for the analysis. The TEP focused on the different formulations of the product Sinovial® [HA 0.8%, HA 1.6%, HA 2%, 800– 1200 kDa, HA 3.2% (1400– 2100 kDa/65– 110 kDa)]. The choice was due to the vast amount of evidence available. The TEP weighed the evidence in two rounds of a Delphi survey; the results, and any disagreement, were discussed in a final session. Three domains were considered: 1) the patients’ characteristics associated with the best results; 2) the contraindications and the conditions linked to increased risk of failure; 3) the clinical conditions in which VS is considered appropriate. The TEP concluded that VS with HA is safe and effective in the treatment of knee and hip OA of grades I to III and that it is possible to undertake VS in other situations (eg grade IV Kellgren-Lawrence – KL); a comprehensive examination of the patient should be performed before the procedure.Keywords: appropriateness, osteoarthritis, personalized medicine, viscosupplementationMigliore AGigliucci GAlekseeva LBannuru RRBlicharski TDiracoglu DGeorgiadis AHamoud HMartusevich NMatucci Cerinic MPerduk JSzerb ITrč TChevalier XDove Medical Pressarticleappropriatenessosteoarthritispersonalized medicineviscosupplementationOrthopedic surgeryRD701-811Diseases of the musculoskeletal systemRC925-935ENOrthopedic Research and Reviews, Vol Volume 13, Pp 255-273 (2021)